Welcome
Support Centre
17 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A feasibility study of an internet-based sexually transmitted infection (STI)/human immunodeficiency virus (HIV) behaviour change intervention
ISRCTN ISRCTN16344388
ClinicalTrials.gov identifier
Public title A feasibility study of an internet-based sexually transmitted infection (STI)/human immunodeficiency virus (HIV) behaviour change intervention
Scientific title
Acronym N/A
Serial number at source G0300712
Study hypothesis To develop and test the feasibility of a novel computer-aided behavioural intervention for STI/HIV prevention, targeting people at high risk, with a view to testing the efficacy of this intervention in a future randomised controlled trial
Lay summary
Ethics approval Not provided at time of registration.
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Sexual Health
Participants - inclusion criteria Patients with an incident sexually transmitted infection (gonorrhoea, chlamydia, infectious syphilis, first clinical episode genital warts, primary genital herpes).
Participants - exclusion criteria 1. Non-English speaker
2. Functional illiteracy for internet use
Anticipated start date 01/09/2005
Anticipated end date 31/08/2007
Status of trial Completed
Patient information material
Target number of participants 360
Interventions Intervention: introduction and access to an internet-based intervention to reduce sexual behaviour risk
Controls: treatment and advice as usual
Primary outcome measure(s) 1. Attrition rate after 6 months
2. Reported sexual risk behaviours
3. Reinfection with an STI by 6 month follow-up point
Secondary outcome measure(s) Not provided at time of registration.
Sources of funding Medical Research Council (MRC) (UK)
Trial website
Publications
Contact name Dr  Helen  Ward
  Address Dept Infectious Disease Epidemiology
Imperial College London
Norfolk Place
  City/town London
  Zip/Postcode W2 1PG
  Country United Kingdom
  Email h.ward@imperial.ac.uk
Sponsor Sponsor to be confirmed - Record provided by the Medical Research Council (UK)
  Address 20 Park Crescent
  City/town London
  Zip/Postcode W1B 1AL
  Country United Kingdom
  Email h.ward@imperial.ac.uk
Date applied 03/05/2005
Last edited 07/09/2009
Date ISRCTN assigned 21/06/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central